The Potential of Antibodies Against the Phosphatidylserine / Prothrombin Complex as a Biomarker in Antiphospholipid Syndrome

The Potential of Antibodies Against the Phosphatidylserine / Prothrombin Complex as a Biomarker in Antiphospholipid Syndrome

Introduction Antibodies against the phosphatidylserine/prothrombin complex aPS/PT are autoantibodies recognizing an epitope formed in the phosphatidylserine/prothrombin complex as a result of conformational changes resulting from the combination and not present in any of the initial components o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Piotr Pasek, Witold Czyż, Julia Kulbacka, Julia Kacperczyk, Marta Chuncia-Ileczko, Michalina Wójcikiewicz, Filip Arczewski, Karol Dziedzic, Maciej Wojszczyk, Damian Zys, Julia Ryniecka
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-02-01
Series:	Journal of Education, Health and Sport
Subjects:	Antiphospholipid syndrome Anti-phosphatidylserine/prothrombin complex antibodies Systemic Lupus Erythematosus Lupus anticoagulant Thrombosis
Online Access:	https://apcz.umk.pl/JEHS/article/view/57631
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01)

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Reviewing the current diagnostic and treatment approaches for myocarditis – analysis of literature
by: Damian Zys, et al.
Published: (2025-01-01)

Diagnosing and Managing LADA: A Review of the Overlooked Diabetes Subtype
by: Maciej Wojszczyk, et al.
Published: (2025-01-01)

Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease
by: Julia Ryniecka, et al.
Published: (2025-01-01)

Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome
by: Oscar Cabrera-Marante, et al.
Published: (2025-08-01)

Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents
by: Marta Chuncia, et al.
Published: (2025-01-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
by: Amr Ashour, et al.
Published: (2023-03-01)

Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome
by: Qing-Nan Zhu, et al.
Published: (2025-08-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19
by: Yu. V. Mikhailova, et al.
Published: (2024-05-01)

A case of primary antiphospholipid syndrome under the mask of systemic lupus erythematosus
by: N. S. Pozhilenko, et al.
Published: (2022-03-01)

ISCHEMIC STROKE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: P. S. Nikitenko, et al.
Published: (2019-07-01)

The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey
by: Salim Mısırcı, et al.
Published: (2024-10-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01)

Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
by: G. M. Tarasova, et al.
Published: (2023-06-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

Antiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature
by: Khemchand N. Moorani, et al.
Published: (2025-03-01)

Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR)
by: T. M. Reshetnyak, et al.
Published: (2024-03-01)

Case Report: Bilateral adrenal hemorrhage in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: Yuwei Wang, et al.
Published: (2025-08-01)

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
by: Can Huang, et al.
Published: (2025-01-01)

Strategies of anticoagulant therapy in various clinical variants of antiphospholipid syndrome
by: A. A. Klimenko, et al.
Published: (2024-06-01)

Phosphatidylserine induce thrombotic tendency and liver damage in obstructive jaundice
by: Muxin Yu, et al.
Published: (2025-03-01)

Procoagulant effect of phosphatidylserine-exposed blood cells, endothelial cells and extracellular vesicles in patients with aortic stenosis
by: Haiyang Wang, et al.
Published: (2025-06-01)

Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation
by: E. A. Orudzhova
Published: (2022-01-01)

Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance
by: Wei Huang, et al.
Published: (2024-12-01)

Significance and Correlation of Lupus Anticoagulant and Anticardiolipin Antibody Assay in High-risk Pregnancy
by: Blessy Mathew, et al.
Published: (2025-05-01)

Liver involvement in patients with systemic lupus erythematosus
by: A. P. Panova, et al.
Published: (2021-05-01)

Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)

Aptasensing biosynthesized phosphatidylserine with a AuNPs nanozyme-based colorimetric aptasensor
by: Sai Wang, et al.
Published: (2024-03-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)